Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
 Index 
 Full text 
Debates
Tuesday, 3 July 2012 - Strasbourg Revised edition

Anti-Counterfeiting Trade Agreement between the EU and its Member States, Australia, Canada, Japan, the Republic of Korea, Mexico, Morocco, New Zealand, Singapore, Switzerland and the USA (debate)
MPphoto
 

  Marielle Gallo (PPE), Blue-card answer.(FR) I hope I have misunderstood. I hope I have misunderstood that you are telling me that counterfeit medicines save lives. Generic medicines are another matter. I heard ‘counterfeit’. There is a big difference, after all! With regard to generic medicines, there is no problem with ACTA. You know this very well. Therefore, I do not understand the relevance of this question.

(The speaker agreed to take a blue-card question under Rule 149(8))

 
Legal notice - Privacy policy